[1]
|
赵京. 中国儿童食物过敏现况[J]. 中华临床免疫和变态反应杂志, 2019, 13(4): 271-275.
|
[2]
|
Pajno, G.B., Fer-nandez-Rivas, M., Arasi, S., et al. (2018) EAACI Guidelines on Allergen Immunotherapy: IgE-Mediated Food Allergy. Allergy, 73, 799-815. https://doi.org/10.1111/all.13319
|
[3]
|
US Food and Drug Administration (2020) FDA Ap-proves First Drug for Treatment of Peanut Allergy for Children.
|
[4]
|
Loh, W. and Tang, M. (2018) Adjuvant Therapies in Food Immunotherapy. Immunology and Allergy Clinics, 38, 89-101.
https://doi.org/10.1016/j.iac.2017.09.008
|
[5]
|
Loh, W.Y. and Tang, M.L.K. (2018) Debates in Allergy Medicine: Oral Immunotherapy Shortens the Duration of Milk and Egg Allergy—The Con Argument. World Allergy Organization Journal, 11, Article No. 12.
https://doi.org/10.1186/s40413-018-0189-0
|
[6]
|
de Silva, D., Rodríguez del Río, P., de Jong, N.W., et al. (2022) Allergen Immunotherapy and/or Biologicals for IgE- Mediated Food Allergy: A Systematic Review and Meta-Analysis. Allergy, 77, 1852-1862.
https://doi.org/10.1111/all.15211
|
[7]
|
Barshow, S.M., Kulis, M.D., Burks, A.W., et al. (2021) Mechanisms of Oral Immunotherapy. Clinical & Experimental Allergy, 51, 527-535. https://doi.org/10.1111/cea.13824
|
[8]
|
Wood, R.A., Sicherer, S.H., Vickery, B.P., et al. (2013) The Natural History of Milk Allergy in an Observational Cohort. Jour-nal of Allergy and Clinical Immunology, 131, 805-812.e4. https://doi.org/10.1016/j.jaci.2012.10.060
|
[9]
|
Jiménez-Saiz, R. and Patil, S.U. (2018) The Multifaceted B Cell Response in Allergen Immunotherapy. Current Allergy and Asthma Reports, 18, 1-8. https://doi.org/10.1007/s11882-018-0819-1
|
[10]
|
Schoos, A.M.M., Bullens, D., Chawes, B.L., et al. (2020) Im-munological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. Frontiers in Immunology, 11, Article ID: 568598. https://doi.org/10.3389/fimmu.2020.568598
|
[11]
|
Jiménez-Saiz, R., Chu, D.K., Waserman, S., et al. (2017) Initiation, Persistence and Exacerbation of Food Allergy. In: Allergy Prevention and Exacerbation, Springer, Cham, 121-144. https://doi.org/10.1007/978-3-319-69968-4_7
|
[12]
|
Syed, A., Garcia, M.A., Lyu, S.C., et al. (2014) Pea-nut oral Immunotherapy Results in Increased Antigen-Induced Regulatory T-Cell Function and Hypomethylation of Forkhead Box Protein 3 (FOXP3). Journal of Allergy and Clinical Immunology, 133, 500-510.e11. https://doi.org/10.1016/j.jaci.2013.12.1037
|
[13]
|
Wood, R.A. (2016) Food Allergen Immunotherapy: Current Status and Prospects for the Future. Journal of Allergy and Clinical Immunology, 137, 973-982. https://doi.org/10.1016/j.jaci.2016.01.001
|
[14]
|
Esmaeilzadeh, H., Alyasin, S., Haghighat, M., et al. (2018) The Ef-fect of Baked Milk on Accelerating Unheated Cow’s Milk Tolerance: A Control Randomized Clinical Trial. Pediatric Al-lergy and Immunology, 29, 747-753.
https://doi.org/10.1111/pai.12958
|
[15]
|
Jiménez-Saiz, R., Belloque, J., Molina, E., et al. (2011) Human Immuno-globulin E (IgE) Binding to Heated and Glycated Ovalbumin and Ovomucoid before and after in Vitro Digestion. Journal of Agricultural and Food Chemistry, 59, 10044-10051. https://doi.org/10.1021/jf2014638
|
[16]
|
Nadeau, K.C., Schneider, L.C., Hoyte, L., et al. (2011) Rapid Oral Desensitization in Combination with Omalizumab Therapy in Pa-tients with Cow’s Milk Allergy. Journal of Allergy and Clinical Immunology, 127, 1622-1624.
https://doi.org/10.1016/j.jaci.2011.04.009
|
[17]
|
Wood, R.A., Kim, J.S., Lindblad, R., et al. (2016) A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab Combined with Oral Immunotherapy for the Treatment of Cow’s Milk Allergy. Journal of Allergy and Clinical Immunology, 137, 1103-1110.e11. https://doi.org/10.1016/j.jaci.2015.10.005
|
[18]
|
Takahashi, M., Soejima, K., Taniuchi, S., et al. (2017) Oral Immu-notherapy Combined with Omalizumab for High- Risk Cow’s Milk Allergy: A Randomized Controlled Trial. Scientific Reports, 7, Article No. 17453.
https://doi.org/10.1038/s41598-017-16730-6
|
[19]
|
Yee, C.S.K., Albuhairi, S., Noh, E., et al. (2019) Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab. The Journal of Allergy and Clinical Immu-nology: In Practice, 7, 451-461.e7.
https://doi.org/10.1016/j.jaip.2018.09.015
|
[20]
|
Nagakura, K., Sato, S., Miura, Y., et al. (2021) A Randomized Trial of Oral Immunotherapy for Pediatric Cow’s Milk- Induced Anaphylaxis: Heated vs Unheated Milk. Pediatric Allergy and Immunology, 32, 161-169.
https://doi.org/10.1111/pai.13352
|
[21]
|
Virkud, Y.V., Burks, A.W., Steele, P.H., et al. (2017) Novel baseline Pre-dictors of Adverse Events during Oral Immunotherapy in Children with Peanut Allergy. Journal of Allergy and Clinical Immunology, 139, 882-888.e5.
https://doi.org/10.1016/j.jaci.2016.07.030
|
[22]
|
Petroni, D. and Spergel, J.M. (2018) Eosinophilic Esophagitis and Symptoms Possibly Related to Eosinophilic Esophagitis in Oral Immunotherapy. Annals of Allergy, Asthma & Immu-nology, 120, 237-240.e4.
https://doi.org/10.1016/j.anai.2017.11.016
|
[23]
|
Burk, C.M., Dellon, E.S., Steele, P.H., et al. (2017) Eosinophilic Esophagitis during Peanut Oral Immunotherapy with Omalizumab. The Journal of Allergy and Clinical Immunology: In Practice, 5, 498-501.
https://doi.org/10.1016/j.jaip.2016.11.010
|
[24]
|
Wright, B.L., Fernandez-Becker, N.Q., Kambham, N., et al. (2018) Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects with IgE-Mediated Peanut Allergy. Frontiers in Immunology, 9, 2624-2624.
https://doi.org/10.3389/fimmu.2018.02624
|
[25]
|
Muraki, M., Gleich, G.J. and Kita, H. (2011) Antigen-Specific IgG and IgA, but Not IgE, Activate the Effector Functions of Eosinophils in the Presence of Antigen. International Archives of Allergy and Immunology, 154, 119-127.
https://doi.org/10.1159/000320226
|
[26]
|
Brandström, J., Vetander, M., Sundqvist, A.C., et al. (2019) Individually Dosed Omalizumab Facilitates Peanut Oral Immunotherapy in Peanut Allergic Adolescents. Clinical & Experimental Al-lergy, 49, 1328-1341.
https://doi.org/10.1111/cea.13469
|
[27]
|
Cao, S., Borro, M., Alonzi, S., et al. (2021) Improvement in Health-Related Quality of Life in Food-Allergic Patients: A Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice, 9, 3705-3714.
https://doi.org/10.1016/j.jaip.2021.05.020
|
[28]
|
Chu, D.K., Wood, R.A., French, S., et al. (2019) Oral Immuno-therapy for Peanut Allergy (PACE): A Systematic Review and Meta-Analysis of Efficacy and Safety. The Lancet, 393, 2222-2232.
https://doi.org/10.1016/S0140-6736(19)30420-9
|
[29]
|
Dunn Galvin, A., McMahon, S., Ponsonby, A.L., et al. (2018) The Longitudinal Impact of Probiotic and Peanut Oral Immunotherapy on Health-Related Quality of Life. Allergy, 73, 560-568. https://doi.org/10.1111/all.13330
|